162) release of Cu B from nanoscale CCS-films compared to that from a conventional CCS f |
163) e contralateral side in the control group compared to that in the BoTA group (P < |
164) 7, and eNOS phosphorylation at Thr495, as compared to that in the control. |
165) es both showed a lower-level distribution compared to that in the plasma, which indi |
166) use calvarial defect model over 4 weeks compared to that in the untreated group. |
167) e pattern accounting for 20% drug release compared to that of OP solution up to 90% |
168) in female Turkish immigrants is higher as compared to that of native-born women of t |
169) bosomal gene was amplified, sequenced and compared to that of other diplozoid taxa. |
170) ein formulations, and its stabilizing was compared to that of other excipients which |
171) ngement of cox2-rrnS in F-type mitogenome compared to that of other freshwater musse |
172) ding 1.0 mg/ml of the UE + HPE extract compared to that of the control (no treatm |
173) to increase the rate of the drug release compared to that of the free drug. |
174) Compared to controls at this stage, exposu |
175) s of animals exposed to d-phenothrin when compared to controls. |
176) of wound contraction and reepithelisation compared to controls. |
177) luteinising hormone (LH) in HCD group as compared to controls. |
178) voxel-wise morphometry in PG subjects as compared to controls. |
179) D was reduced in CHD patients (P<0.05) compared to controls. |
180) novel learning of spatial configurations compared to controls. |
181) wer at each sampling time post-activation compared to controls. |
182) re highly expressed in hemangioma samples compared to controls. |
183) ntents at various stages of wound healing compared to controls. |
184) re were more likely to be innovators when compared to other centrally-located PCAs, |
185) a lower rate of graft versus host disease compared to other donor sources. |
186) he weakest intentions to report rape when compared to other ethnic groups, cultural |
187) elevated risk for depression and suicide compared to other ethnic groups. |
188) splatin-loaded targeted-nanogel treatment compared to other formulations. |
189) decreased significantly in the SFNC group compared to other groups (p<0.05). |
190) ontrolled statistically when the IPDS was compared to other measures of psychopathol |
191) berculosis infection (LTBI) treatment, as compared to other referral groups, and to |
192) (0.02) and it was very low (0.011), when compared to other species of Gallus. |
193) ad significantly lower risk-adjusted rate compared to other surgical inpatients for |
194) in patients with systemic sclerosis (SSc) compared to healthy controls by measuring |
|